RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Product Development in SMEs

Product Development in SMEs

Posted 01 October 2008

Product development plays an important role in the pharmaceutical and medical device sectors. The approach used by large multinationals with substantial R&D budgets, as compared to small and medium-size enterprises (SMEs), however, may be very different. In addition, the path used by innovative SMEs as compared to generic or "me too" product manufacturers is likely to be different. SMEs are characterized by limited R&D budgets and usually need to stretch resources. Even SMEs based upon venture capital have fewer resources and smaller R&D budgets than very large, research-focused companies.


© 2022 Regulatory Affairs Professionals Society.